Delivery Order SPE2DB25D3404-SPE2DB25FUNRZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,981.10 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication. This firm fixed-price delivery order, issued on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a federal contract worth up to $1,361.84 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Veklury (Remdesivir). The contract has a ceiling value of $8,716.84 and a period of performance through June 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,618.40 contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a COVID-19 treatment medication. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Veklury (Remdesivir) 100 mg vials. The contract, valued at $13,618.40, is a firm fixed-price delivery order with a period of performance through June 24, 2024. Amerisourcebergen, through its Corporate Office division, leverages its extensive pharmaceutical supply chain to efficiently deliver critical medical products to the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNRZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill critical medical supply requirements across multiple therapeutic domains through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 6/3/25 |